Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV

• US 9,988,645 B2
• Filed: 02/03/2017
• Issued: 06/05/2018
• Est. Priority Date: 06/21/2006
• Status: Active Grant

• Current Assignee: Uniqure Ip B.V. (uniQure N.V.)
• Original Assignee: Uniqure Ip B.V. (uniQure N.V.)
• Inventors: Hermens, Wilhelmus Theodorus Johannes Maria Christiaan, Haast, Saskia Jacoba Petronella, Biesmans, Dennis Johan, Bakker, Andrew Christian
• Primary Examiner(s): Chestnut, Barry A
• Application Number:
  US15/424,560
• Publication Number:
  US 20170145440A1
• Time in Patent Office: 487 Days
• CPC Class Codes: C07K 14/005 from viruses
• CPC Class Codes: C12N 15/86 Viral vectors
• CPC Class Codes: C12N 2710/14043 viral genome or elements thereof as genetic vectore
• CPC Class Codes: C12N 2710/14044 Chimeric viral vector comprising heterologous viral elements for production of another viral vector
• CPC Class Codes: C12N 2710/14143 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2710/14144 Chimeric viral vector comprising heterologous viral elements for production of another viral vector
• CPC Class Codes: C12N 2710/14152 relating to complementing cells and packaging systems for producing virus or viral particles
• CPC Class Codes: C12N 2750/14121 Viruses as such, e.g. new isolates, mutants or their genomic sequences
• CPC Class Codes: C12N 2750/14122 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• CPC Class Codes: C12N 2750/14143 viral genome or elements thereof as genetic vector
• CPC Class Codes: C12N 2750/14151 Methods of production or purification of viral material
• CPC Class Codes: C12N 2750/14152 relating to complementing cells and packaging systems for producing virus or viral particles
• CPC Class Codes: C12N 2800/105 for insects
• CPC Class Codes: C12N 2800/50 Vectors for producing vectors
• CPC Class Codes: C12N 7/00 Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00

Abstract

The present invention relates nucleic acid constructs for the production of recombinant parvoviral (e.g. adeno-associated viral) vectors in insect cells, to insect cells comprising such constructs and to methods wherein the cells are used to produce recombinant parvoviral virions. The insect cells preferably comprise a first nucleotide sequence encoding the parvoviral rep proteins whereby the initiation codon for translation of the parvoviral Rep78 protein is a suboptimal initiation codon that effects partial exon skipping upon expression in insect cells. The insect cell further comprises a second nucleotide sequence comprising at least one parvoviral (AA V) inverted terminal repeat (ITR) nucleotide sequence and a third nucleotide sequence comprising a sequences coding for the parvoviral capsid proteins.

Claims

1. A nucleic acid construct comprising a nucleotide sequence encoding parvoviral proteins Rep78 and Rep52, wherein the nucleotide sequence consisting essentially of a single Rep78 coding sequence, a first expression control sequence, and a second expression control sequence, the single Rep78 coding sequence being operably linked to the first expression control sequence for expressing in the insect cell and the second expression control sequence located within the Rep78 coding sequence for expressing Rep52 in the insect cell.

2. The nucleic acid construct of claim 1, wherein the first expression control sequence comprises an initiation codon.

3. The nucleic acid construct of claim 1, wherein the first expression control sequence comprises a promoter and an initiation codon.

4. The nucleic acid construct of claim 3, wherein the promoter is selected from the group consisting of polyhedron promoter, p10 promoter, p35 promoter, IE-1 promoter, and delta-IE1 promoter.

5. The nucleic acid construct of claim 3, wherein the initiation codon is a suboptimal initiation codon.

6. The nucleic acid construct of claim 1, wherein the second expression control sequence comprises an initiation codon.

7. The nucleic acid construct of claim 1, wherein the first and second expression control sequences comprise a promoter.

8. The nucleic acid construct of claim 1, wherein the nucleic acid sequence further comprises a polyadenylation sequence at its 3′

-end.

9. The nucleic acid construct of claim 1, wherein the nucleic acid construct further comprises a Cap protein coding sequence operably linked to an expression control sequence for expressing a Cap protein in an insect cell.

10. The nucleic acid construct of claim 1, wherein the nucleic acid construct is inserted into a baculovirus vector.

11. A method for producing recombinant parvovirus Rep78 and Rep52 proteins in an insect cell, comprising transfecting an insect cell with the nucleic acid construct of claim 1, wherein both Rep78 protein and Rep52 protein are produced in the insect cell.

12. The method of claim 11, wherein the insect cell is transfected with a baculovirus vector comprising the nucleic acid construct.

13. The method of claim 11, wherein the Rep78 and Rep52 proteins are produced in a molar ratio in the range of 1:

10 to 10;

1.

14. The method of claim 11, further comprising transfecting the insect cell with a second nucleic acid construct comprising at least one parvoviral inverted terminal repeat (ITR) nucleotide sequence.

15. The method of claim 11, wherein the insect cell is selected from the group consisting of Se301, Seizd2109, Seucr1, sf9, Sf900+, Sf21, Bti-Tn-5b1-4, Mg-1, Tn368, Hzam1, Ha2302, Hz2e5, High five and Express+.

16. The method of claim 11, further comprising transfecting the insect cell with a second nucleotide sequence comprising at least one parvoviral inverted terminal repeat (ITR) sequence and a third nucleotide sequence comprising at least one parvoviral Cap protein encoding sequence operably linked to an expression control sequence for expressing the at least one Cap protein in an insect cell.

17. The method of claim 16, wherein upon culturing the insect cell recombinant parvoviral virions are produced in the insect cell.

18. The method of claim 17, further comprising recovering the recombinant parvoviral virions.